Clinical trials
Gastrointestinal Stromal Tumors trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 3 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Recruiting | 9 |
| Active, not recruiting | 4 |
| Unknown status | 3 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 10 |
| Centre Leon Berard | 4 |
| Deciphera Pharmaceuticals, LLC | 4 |
| European Organisation for Research and Treatment of Cancer - EORTC | 4 |
| Pfizer | 4 |
| Blueprint Medicines Corporation | 3 |
| AB Science | 2 |
| Bayer | 2 |
| Centre Oscar Lambret | 2 |
| GlaxoSmithKline | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastrointestinal Stromal Tumors | 48 |
| Neoplasm Metastasis | 5 |
| Neoplasms | 5 |
| Sarcoma | 5 |
| Biliary Tract Neoplasms | 3 |
| Breast Neoplasms | 3 |
| Carcinoma, Hepatocellular | 3 |
| Gastrointestinal Neoplasms | 3 |
| Glioma | 3 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 |
Trials
Showing 26 to 48 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.